ID   NEB2_RAT                Reviewed;         817 AA.
AC   O35274;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   22-JUL-2015, entry version 127.
DE   RecName: Full=Neurabin-2;
DE   AltName: Full=Neurabin-II;
DE   AltName: Full=Neural tissue-specific F-actin-binding protein II;
DE   AltName: Full=PP1bp134;
DE   AltName: Full=Protein phosphatase 1 regulatory subunit 9B;
DE   AltName: Full=Spinophilin;
DE   AltName: Full=p130;
GN   Name=Ppp1r9b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9275233; DOI=10.1073/pnas.94.18.9956;
RA   Allen P.B., Ouimet C.C., Greengard P.;
RT   "Spinophilin, a novel protein phosphatase 1 binding protein localized
RT   to dendritic spines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:9956-9961(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 4-24;
RP   164-182; 199-242; 449-480; 678-689 AND 776-791.
RC   TISSUE=Brain;
RX   PubMed=9452470; DOI=10.1074/jbc.273.6.3470;
RA   Satoh A., Nakanishi H., Obaishi H., Wada M., Takahashi K., Satoh K.,
RA   Hirao K., Nishioka H., Hata Y., Mizoguchi A., Takai Y.;
RT   "Neurabin-II/spinophilin. An actin filament-binding protein with one
RT   pdz domain localized at cadherin-based cell-cell adhesion sites.";
RL   J. Biol. Chem. 273:3470-3475(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 100-767, AND INTERACTION WITH D2DR.
RX   PubMed=10391935; DOI=10.1074/jbc.274.28.19894;
RA   Smith F.D., Oxford G.S., Milgram S.L.;
RT   "Association of the D2 dopamine receptor third cytoplasmic loop with
RT   spinophilin, a protein phosphatase-1-interacting protein.";
RL   J. Biol. Chem. 274:19894-19900(1999).
RN   [4]
RP   CHARACTERIZATION.
RC   TISSUE=Brain;
RX   PubMed=10585469; DOI=10.1074/jbc.274.50.35845;
RA   MacMillan L.B., Bass M.A., Cheng N., Howard E.F., Tamura M.,
RA   Strack S., Wadzinski B.E., Colbran R.J.;
RT   "Brain actin-associated protein phosphatase 1 holoenzymes containing
RT   spinophilin, neurabin, and selected catalytic subunit isoforms.";
RL   J. Biol. Chem. 274:35845-35854(1999).
RN   [5]
RP   INTERACTION WITH TGN38.
RX   PubMed=10514494; DOI=10.1074/jbc.274.42.30080;
RA   Stephens D.J., Banting G.;
RT   "Direct interaction of the trans-Golgi network membrane protein,
RT   TGN38, with the F-actin binding protein, neurabin.";
RL   J. Biol. Chem. 274:30080-30086(1999).
RN   [6]
RP   CHARACTERIZATION, INTERACTION WITH PP1, AND MUTAGENESIS.
RX   PubMed=10194355; DOI=10.1021/bi982900m;
RA   Hsieh-Wilson L.C., Allen P.B., Watanabe T., Nairn A.C., Greengard P.;
RT   "Characterization of the neuronal targeting protein spinophilin and
RT   its interactions with protein phosphatase-1.";
RL   Biochemistry 38:4365-4373(1999).
RN   [7]
RP   INTERACTION WITH ADRA2A; ADRA2B AND ADRA2C.
RX   PubMed=11154706; DOI=10.1074/jbc.M011679200;
RA   Richman J.G., Brady A.E., Wang Q., Hensel J.L., Colbran R.J.,
RA   Limbird L.E.;
RT   "Agonist-regulated Interaction between alpha2-adrenergic receptors and
RT   spinophilin.";
RL   J. Biol. Chem. 276:15003-15008(2001).
RN   [8]
RP   SUBCELLULAR LOCATION, INTERACTION WITH ACTIN AND PPP1CA,
RP   PHOSPHORYLATION AT SER-94; SER-100 AND SER-177, AND MUTAGENESIS OF
RP   SER-17; SER-59; SER-87; SER-94; SER-99; SER-100; SER-122; SER-126 AND
RP   SER-177.
RX   PubMed=12417592; DOI=10.1074/jbc.M205754200;
RA   Hsieh-Wilson L.C., Benfenati F., Snyder G.L., Allen P.B., Nairn A.C.,
RA   Greengard P.;
RT   "Phosphorylation of spinophilin modulates its interaction with actin
RT   filaments.";
RL   J. Biol. Chem. 278:1186-1194(2003).
RN   [9]
RP   INTERACTION WITH TIAM1 AND RASGRF1.
RX   PubMed=12531897; DOI=10.1074/jbc.M207876200;
RA   Buchsbaum R.J., Connolly B.A., Feig L.A.;
RT   "Regulation of p70 S6 kinase by complex formation between the Rac
RT   guanine nucleotide exchange factor (Rac-GEF) Tiam1 and the scaffold
RT   spinophilin.";
RL   J. Biol. Chem. 278:18833-18841(2003).
RN   [10]
RP   INTERACTION WITH ACTIN.
RX   PubMed=15135218; DOI=10.1016/j.molbrainres.2003.12.020;
RA   Barnes A.P., Smith F.D. III, VanDongen H.M., VanDongen A.M.,
RA   Milgram S.L.;
RT   "The identification of a second actin-binding region in
RT   spinophilin/neurabin II.";
RL   Brain Res. Mol. Brain Res. 124:105-113(2004).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15514983; DOI=10.1002/cne.20313;
RA   Ouimet C.C., Katona I., Allen P., Freund T.F., Greengard P.;
RT   "Cellular and subcellular distribution of spinophilin, a PP1
RT   regulatory protein that bundles F-actin in dendritic spines.";
RL   J. Comp. Neurol. 479:374-388(2004).
RN   [12]
RP   PHOSPHORYLATION BY CAMK2, PHOSPHORYLATION AT SER-100 AND SER-116, AND
RP   MUTAGENESIS OF SER-100 AND SER-116.
RX   PubMed=15228588; DOI=10.1111/j.1471-4159.2004.02491.x;
RA   Grossman S.D., Futter M., Snyder G.L., Allen P.B., Nairn A.C.,
RA   Greengard P., Hsieh-Wilson L.C.;
RT   "Spinophilin is phosphorylated by Ca2+/calmodulin-dependent protein
RT   kinase II resulting in regulation of its binding to F-actin.";
RL   J. Neurochem. 90:317-324(2004).
RN   [13]
RP   FUNCTION IN DENDRITIC SPINE MORPHOGENESIS, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH PPP1R2.
RX   PubMed=15743906; DOI=10.1091/mbc.E04-12-1054;
RA   Terry-Lorenzo R.T., Roadcap D.W., Otsuka T., Blanpied T.A.,
RA   Zamorano P.L., Garner C.C., Shenolikar S., Ehlers M.D.;
RT   "Neurabin/protein phosphatase-1 complex regulates dendritic spine
RT   morphogenesis and maturation.";
RL   Mol. Biol. Cell 16:2349-2362(2005).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH RGS1; RGS2; RGS4; RGS19; ADRA1B.
RX   PubMed=15793568; DOI=10.1038/ncb1237;
RA   Wang X., Zeng W., Soyombo A.A., Tang W., Ross E.M., Barnes A.P.,
RA   Milgram S.L., Penninger J.M., Allen P.B., Greengard P., Muallem S.;
RT   "Spinophilin regulates Ca2+ signalling by binding the N-terminal
RT   domain of RGS2 and the third intracellular loop of G-protein-coupled
RT   receptors.";
RL   Nat. Cell Biol. 7:405-411(2005).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 417-583 IN COMPLEX WITH
RP   HUMAN PP1CA.
RX   PubMed=20305656; DOI=10.1038/nsmb.1786;
RA   Ragusa M.J., Dancheck B., Critton D.A., Nairn A.C., Page R., Peti W.;
RT   "Spinophilin directs protein phosphatase 1 specificity by blocking
RT   substrate binding sites.";
RL   Nat. Struct. Mol. Biol. 17:459-464(2010).
CC   -!- FUNCTION: Seems to act as a scaffold protein in multiple signaling
CC       pathways. Modulates excitatory synaptic transmission and dendritic
CC       spine morphology. Binds to actin filaments (F-actin) and shows
CC       cross-linking activity. Binds along the sides of the F-actin. May
CC       play an important role in linking the actin cytoskeleton to the
CC       plasma membrane at the synaptic junction. Believed to target
CC       protein phosphatase 1/PP1 to dendritic spines, which are rich in
CC       F-actin, and regulates its specificity toward ion channels and
CC       other substrates, such as AMPA-type and NMDA-type glutamate
CC       receptors. Plays a role in regulation of G-protein coupled
CC       receptor signaling, including dopamine D2 receptors and alpha-
CC       adrenergic receptors. May establish a signaling complex for
CC       dopaminergic neurotransmission through D2 receptors by linking
CC       receptors downstream signaling molecules and the actin
CC       cytoskeleton. Binds to ADRA1B and RGS2 and mediates regulation of
CC       ADRA1B signaling. May confer to Rac signaling specificity by
CC       binding to both, RacGEFs and Rac effector proteins. Probably
CC       regulates p70 S6 kinase activity by forming a complex with TIAM1.
CC       Required for hepatocyte growth factor (HGF)-induced cell migration
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with DCLK2 (By similarity). Possibly exists as
CC       a homodimer, homotrimer or a homotetramer. Interacts with F-actin,
CC       PPP1CA, neurabin-1, TGN38 and D(2) dopamine receptor. Interacts
CC       with RGS1, RGS2, RGS4, RGS19 and ADRA1B, ADRA2A, ADRA2B, ADRA2C,
CC       CDKN2A, PPP1R2, RASGFR1 and TIAM1. Interacts (via C-terminus) with
CC       SPATA13 (via C-terminal tail) (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P61169:Drd2; NbExp=2; IntAct=EBI-80022, EBI-80012;
CC       P63088:Ppp1cc; NbExp=3; IntAct=EBI-80022, EBI-80049;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Nucleus
CC       {ECO:0000250}. Cell junction, synapse. Cell junction, adherens
CC       junction. Cell projection, dendritic spine. Cytoplasm
CC       {ECO:0000250}. Cell membrane {ECO:0000250}. Cell projection,
CC       lamellipodium {ECO:0000250}. Cell projection, filopodium
CC       {ECO:0000250}. Cell projection, ruffle membrane {ECO:0000250}.
CC       Note=Enriched at synapse and cadherin-based cell-cell adhesion
CC       sites. In neurons, both cytosolic and membrane-associated, and
CC       highly enriched in the postsynaptic density apposed to exitatory
CC       synapses. Colocalizes with PPP1R2 at actin-rich adherens junctions
CC       in epithelial cells and in dendritic spines. Accumulates in the
CC       lamellipodium, filopodium and ruffle membrane in response to
CC       hepatocyte growth factor (HGF) treatment (By similarity).
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Abundantly expressed in the brain.
CC       Expressed at highest levels in hippocampus and at lower levels in
CC       the cortex, cerebellum and brainstem. Localizes to the dendritic
CC       spines of neurons. Also localizes to aspiny neurons, such as
CC       GABAergic interneurons.
CC   -!- DEVELOPMENTAL STAGE: Expression is low during embryogenesis and
CC       increases around postnatal day 21.
CC   -!- DOMAIN: The PP1 binding region is natively unstructured, upon PP1
CC       binding, it acquires structure, blocks a substrate-binding site,
CC       and restricts PP1 phosphatase specificity to a subset of
CC       substrates.
CC   -!- PTM: Stimulation of D1 (but not D2) dopamine receptors induces
CC       Ser-94 and Ser-177 phosphorylation. Dephosphorylation of these
CC       residues is mediated by PP1 and possibly PP2A. Spinophilin
CC       unphosphorylated or phosphorylated at Ser-94 is concentrated in
CC       the postsynaptic density, whereas spinophilin phosphorylated at
CC       Ser-177 is absent from the postsynaptic density and enriched in
CC       the cytosol. Phosphorylation of spinophilin disrupts its
CC       association with F-actin, but does not affect its binding to PP1.
CC       {ECO:0000269|PubMed:12417592, ECO:0000269|PubMed:15228588}.
CC   -!- SIMILARITY: Contains 1 PDZ (DHR) domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00143}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF016252; AAB72005.1; -; mRNA.
DR   EMBL; AF027181; AAC05183.1; -; Genomic_DNA.
DR   PIR; T03852; T03852.
DR   RefSeq; NP_445926.1; NM_053474.1.
DR   UniGene; Rn.6764; -.
DR   PDB; 2G5M; NMR; -; B=493-602.
DR   PDB; 3EGG; X-ray; 1.85 A; C/D=417-583.
DR   PDB; 3EGH; X-ray; 2.00 A; C/D=417-583.
DR   PDBsum; 2G5M; -.
DR   PDBsum; 3EGG; -.
DR   PDBsum; 3EGH; -.
DR   ProteinModelPortal; O35274; -.
DR   SMR; O35274; 492-602.
DR   DIP; DIP-30882N; -.
DR   IntAct; O35274; 4.
DR   MINT; MINT-8057892; -.
DR   STRING; 10116.ENSRNOP00000005498; -.
DR   PhosphoSite; O35274; -.
DR   PaxDb; O35274; -.
DR   PRIDE; O35274; -.
DR   Ensembl; ENSRNOT00000089497; ENSRNOP00000074026; ENSRNOG00000052113.
DR   GeneID; 84686; -.
DR   KEGG; rno:84686; -.
DR   UCSC; RGD:632281; rat.
DR   CTD; 84687; -.
DR   RGD; 632281; Ppp1r9b.
DR   eggNOG; NOG314102; -.
DR   GeneTree; ENSGT00390000010033; -.
DR   HOGENOM; HOG000252962; -.
DR   HOVERGEN; HBG005213; -.
DR   InParanoid; O35274; -.
DR   KO; K17551; -.
DR   OMA; HLNNAAN; -.
DR   OrthoDB; EOG7XM2WV; -.
DR   PhylomeDB; O35274; -.
DR   EvolutionaryTrace; O35274; -.
DR   NextBio; 617274; -.
DR   PRO; PR:O35274; -.
DR   Proteomes; UP000002494; Unassembled WGS sequence.
DR   Genevisible; O35274; RN.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:RGD.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0044327; C:dendritic spine head; IDA:RGD.
DR   GO; GO:0032591; C:dendritic spine membrane; IDA:RGD.
DR   GO; GO:0044326; C:dendritic spine neck; IDA:RGD.
DR   GO; GO:0030175; C:filopodium; ISS:UniProtKB.
DR   GO; GO:0030426; C:growth cone; IDA:RGD.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:RGD.
DR   GO; GO:0032587; C:ruffle membrane; ISS:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IDA:RGD.
DR   GO; GO:0031749; F:D2 dopamine receptor binding; IPI:RGD.
DR   GO; GO:0019900; F:kinase binding; IPI:RGD.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:RGD.
DR   GO; GO:0032403; F:protein complex binding; IDA:RGD.
DR   GO; GO:0004672; F:protein kinase activity; IDA:RGD.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IDA:RGD.
DR   GO; GO:0004864; F:protein phosphatase inhibitor activity; IDA:RGD.
DR   GO; GO:0030042; P:actin filament depolymerization; IEP:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; IEA:Ensembl.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IEP:RGD.
DR   GO; GO:0071482; P:cellular response to light stimulus; IDA:RGD.
DR   GO; GO:0071315; P:cellular response to morphine; ISS:UniProtKB.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0016358; P:dendrite development; IEA:Ensembl.
DR   GO; GO:0046847; P:filopodium assembly; ISS:UniProtKB.
DR   GO; GO:0060179; P:male mating behavior; IEP:RGD.
DR   GO; GO:0032515; P:negative regulation of phosphoprotein phosphatase activity; IDA:RGD.
DR   GO; GO:1903829; P:positive regulation of cellular protein localization; IDA:RGD.
DR   GO; GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IDA:RGD.
DR   GO; GO:1903119; P:protein localization to actin cytoskeleton; IMP:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:GOC.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:InterPro.
DR   GO; GO:2000474; P:regulation of opioid receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0050804; P:regulation of synaptic transmission; IEA:InterPro.
DR   GO; GO:0061458; P:reproductive system development; IEP:RGD.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0035902; P:response to immobilization stress; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0034695; P:response to prostaglandin E; IEP:RGD.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR029921; NEB2.
DR   InterPro; IPR001478; PDZ.
DR   PANTHER; PTHR16154:SF24; PTHR16154:SF24; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Cell junction; Cell membrane;
KW   Cell projection; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Developmental protein; Differentiation;
KW   Direct protein sequencing; Membrane; Neurogenesis; Nucleus;
KW   Phosphoprotein; Reference proteome; Synapse.
FT   CHAIN         1    817       Neurabin-2.
FT                                /FTId=PRO_0000071509.
FT   DOMAIN      496    584       PDZ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00143}.
FT   REGION        1    154       Actin-binding.
FT   REGION      100    371       Interacts with D(2) dopamine receptor.
FT   REGION      164    282       Actin-binding.
FT   REGION      169    255       Interacts with ADRA2A, ADRA2B and ADRA2C.
FT   REGION      417    494       Interacts with protein phosphatase 1.
FT   REGION      480    525       Interacts with RGS2.
FT   REGION      595    816       Interacts with TGN38.
FT   COILED      595    616       {ECO:0000255}.
FT   COILED      665    816       {ECO:0000255}.
FT   MOTIF       575    578       PP1-binding motif.
FT   COMPBIAS    253    260       Poly-Pro.
FT   MOD_RES      15     15       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6R891}.
FT   MOD_RES      17     17       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6R891}.
FT   MOD_RES      94     94       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:12417592}.
FT   MOD_RES     100    100       Phosphoserine; by CaMK2.
FT                                {ECO:0000269|PubMed:12417592,
FT                                ECO:0000269|PubMed:15228588}.
FT   MOD_RES     116    116       Phosphoserine; by CaMK2.
FT                                {ECO:0000269|PubMed:15228588}.
FT   MOD_RES     177    177       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:12417592}.
FT   MOD_RES     192    192       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q96SB3}.
FT   MOD_RES     205    205       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6R891}.
FT   MOD_RES     207    207       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q96SB3}.
FT   MOD_RES     438    438       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q96SB3}.
FT   MOD_RES     658    658       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q96SB3}.
FT   MUTAGEN      17     17       S->A: No effect on phosphorylation.
FT                                {ECO:0000269|PubMed:12417592}.
FT   MUTAGEN      59     59       S->A: No effect on phosphorylation.
FT                                {ECO:0000269|PubMed:12417592}.
FT   MUTAGEN      87     87       S->A: No effect on phosphorylation.
FT                                {ECO:0000269|PubMed:12417592}.
FT   MUTAGEN      94     94       S->A: Diminishes phosphorylation.
FT                                {ECO:0000269|PubMed:12417592}.
FT   MUTAGEN      99     99       S->A: No effect on phosphorylation.
FT                                {ECO:0000269|PubMed:12417592}.
FT   MUTAGEN     100    100       S->A: Diminishes phosphorylation.
FT                                {ECO:0000269|PubMed:12417592,
FT                                ECO:0000269|PubMed:15228588}.
FT   MUTAGEN     116    116       S->A: Diminishes phosphorylation.
FT                                {ECO:0000269|PubMed:15228588}.
FT   MUTAGEN     122    122       S->A: No effect on phosphorylation.
FT                                {ECO:0000269|PubMed:12417592}.
FT   MUTAGEN     126    126       S->A: No effect on phosphorylation.
FT                                {ECO:0000269|PubMed:12417592}.
FT   MUTAGEN     177    177       S->A: Diminishes phosphorylation.
FT                                {ECO:0000269|PubMed:12417592}.
FT   MUTAGEN     447    451       Missing: Abolishes protein phosphatase 1
FT                                binding. {ECO:0000269|PubMed:10194355}.
FT   MUTAGEN     451    451       F->A: Abolishes protein phosphatase 1
FT                                binding. {ECO:0000269|PubMed:10194355}.
FT   STRAND      431    434       {ECO:0000244|PDB:3EGG}.
FT   STRAND      456    461       {ECO:0000244|PDB:3EGG}.
FT   TURN        464    466       {ECO:0000244|PDB:3EGG}.
FT   HELIX       476    489       {ECO:0000244|PDB:3EGG}.
FT   STRAND      492    500       {ECO:0000244|PDB:3EGG}.
FT   STRAND      505    513       {ECO:0000244|PDB:3EGG}.
FT   STRAND      515    518       {ECO:0000244|PDB:3EGG}.
FT   STRAND      521    531       {ECO:0000244|PDB:3EGG}.
FT   HELIX       536    540       {ECO:0000244|PDB:3EGG}.
FT   STRAND      548    552       {ECO:0000244|PDB:3EGG}.
FT   HELIX       562    571       {ECO:0000244|PDB:3EGG}.
FT   STRAND      574    582       {ECO:0000244|PDB:3EGG}.
SQ   SEQUENCE   817 AA;  89646 MW;  D31D3E94EE2FFB6A CRC64;
     MMKTEPRGPG GPLRSASPHR SAYEAGIQAL KPPDAPGPDE APKAAHHKKY GSNVHRIKSM
     FLQMGTTTGP PGEAGGASGM AEAPRASDRG VRLSLPRASS LNENVDHSAL LKLGTSVSER
     VSRFDSKPAP SAQPAPPPHP PSRLQETRKL FERSVPAASG GDKEAVARRL LRQERASLQD
     RKLDVVVRFN GSTEALDKLD ADAVSPTVSQ LSAVFEKADS RTGLHRAPGP PRAAGAPQVN
     SKLVTKRSRV FQPPPPPPAP SGDAATEKDR GPGGQQPPQH RVAPARPPPK PREVRKIKPV
     EVEESGESEA ESAPGEVIQA EVTVHAALEN GSTTATTASP APEEPKAEAV PEEEASSSVA
     TLERGVDNGR APDMAPEEVD ESKKEDFSEA DLVDVSAYSG LGEDSGGSAL EEDDEEDEED
     GEPPYEPESG CVEIPGLSEE EDPAPSRKIH FSTAPIQVFS TYSNEDYDRR NEDVDPMAAS
     AEYELEKRVE RLELFPVELE KDSEGLGISI IGMGAGADMG LEKLGIFVKT VTEGGAAHRD
     GRIQVNDLLV EVDGTSLVGV TQSFAASVLR NTKGRVRFMI GRERPGEQSE VAQLIQQTLE
     QERWQREMME QRYAQYGEDD EETGEYATDE DEELSPTFPG GEMAIEVFEL AENEDALSPV
     EMEPEKLVHK FKELQIKHAV TEAEIQQLKR KLQSLEQEKG RWRVEKAQLE QSVEENKERM
     EKLEGYWGEA QSLCQAVDEH LRETQAQYQA LERKYSKAKR LIKDYQQKEI EFLKKETAQR
     RVLEESELAR KEEMDKLLDK ISELEGNLQT LRNSNST
//
